Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.82
-0.1800-0.64%
Post-market: 27.81-0.0100-0.04%19:59 EDT
Volume:44.43M
Turnover:1.23B
Market Cap:158.18B
PE:36.61
High:28.00
Open:27.90
Low:27.48
Close:28.00
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.44
T/O Rate:0.79%
Dividend:1.72
Dividend Rate:6.18%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.86
PE(LYR):20.39

Loading ...

Pfizer - Expects $3 Bln Net Cost Savings from Manufacturing Optimization Program Through 2029

THOMSON REUTERS
·
Aug 04

Pfizer: Announces Expansion of Productivity Enhancement Initiatives

THOMSON REUTERS
·
Aug 04

Pfizer Q2 EPS USD -0.04

THOMSON REUTERS
·
Aug 04

Morning BID Americas-Earnings Overload

Reuters
·
Aug 04

Caterpillar, Pfizer and 3 Stocks to Watch Heading Into Tuesday

Benzinga Earnings
·
Aug 04

Stocks to Watch: Palantir, SpaceX, HSBC

Dow Jones
·
Aug 04

Pfizer Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Benzinga Earnings
·
Aug 04

NYSE Most Active Issues

Dow Jones
·
Aug 04

Top News Today/Canada: WestJet Strike Grounds Hundreds of Flights in Canada

Dow Jones
·
Aug 04

Pfizer’s Quiet Pipeline Push Could Ignite PFE Rally

TIPRANKS
·
Aug 01

Moderately bullish activity in Pfizer with shares up 0.46%

TIPRANKS
·
Aug 01

LITFULO Vitiligo Win And New COVID Shot Could Be A Game Changer For Pfizer (PFE)

Simply Wall St.
·
Jul 31

Pfizer’s Symbiotic-Lung-10 Trial: A Fresh Lung Cancer Bet with Pipeline Upside for PFE

TIPRANKS
·
Jul 31

Pfizer Prepares Global Regulatory Litfulo Filings Following Skin Pigment Improvements In Late-Stage Trials

Benzinga_recent_news
·
Jul 31

Pfizer's Litfulo Achieves Primary Goal in Vitiligo Study

Deep News
·
Jul 30

Pfizer's Litfulo Hits Endpoints in Nonsegmental Vitiligo Studies

Dow Jones
·
Jul 30

Pfizer's Oral Drug Restores Skin Pigmentation in Late-stage Vitiligo Trials

Reuters
·
Jul 30

Pfizer - More Patients on Litfulo Achieve F-Vasi75 and T-Vasi50 at Week 52 Versus Placebo

THOMSON REUTERS
·
Jul 30

Pfizer: Plans to Initiate Pivotal Study Evaluating Litfulo for Treatment of Moderate Alopecia Areata in 2026

THOMSON REUTERS
·
Jul 30

Pfizer - to Submit Global Regulatory Filings for Litfulo in Nonsegmental Vitiligo

THOMSON REUTERS
·
Jul 30